6.09
price down icon0.98%   -0.06
after-market 시간 외 거래: 6.14 0.05 +0.82%
loading
전일 마감가:
$6.15
열려 있는:
$6.21
하루 거래량:
750.65K
Relative Volume:
0.57
시가총액:
$166.97M
수익:
$160.43M
순이익/손실:
$-227.64M
주가수익비율:
-0.0886
EPS:
-68.77
순현금흐름:
$-170.79M
1주 성능:
-10.83%
1개월 성능:
+27.41%
6개월 성능:
+59.01%
1년 성능:
+1.67%
1일 변동 폭
Value
$5.99
$6.57
1주일 범위
Value
$5.99
$7.00
52주 변동 폭
Value
$1.38
$7.34

아제너스 Stock (AGEN) Company Profile

Name
명칭
Agenus Inc
Name
전화
781-674-4410
Name
주소
3 FORBES ROAD, LEXINGTON, MA
Name
직원
316
Name
트위터
@Agenus_Bio
Name
다음 수익 날짜
2024-12-05
Name
최신 SEC 제출 서류
Name
AGEN's Discussions on Twitter

AGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AGEN
Agenus Inc
6.09 187.26M 160.43M -227.64M -170.79M -68.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

아제너스 Stock (AGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-04 업그레이드 H.C. Wainwright Neutral → Buy
2024-07-19 다운그레이드 Robert W. Baird Outperform → Neutral
2024-07-18 다운그레이드 H.C. Wainwright Buy → Neutral
2024-07-18 다운그레이드 William Blair Outperform → Mkt Perform
2023-06-06 개시 Robert W. Baird Outperform
2023-02-28 재개 H.C. Wainwright Buy
2022-09-28 개시 SMBC Nikko Outperform
2021-12-16 개시 H.C. Wainwright Buy
2019-11-19 재개 B. Riley FBR Buy
2019-04-22 개시 B. Riley FBR Buy
2016-10-28 다운그레이드 H.C. Wainwright Buy → Neutral
2016-10-27 재확인 Maxim Group Buy
2016-03-11 업그레이드 Maxim Group Hold → Buy
2015-12-16 개시 Jefferies Buy
2015-10-27 다운그레이드 Maxim Group Buy → Hold
2015-07-27 재확인 MLV & Co Buy
2015-06-11 개시 Oppenheimer Outperform
2015-01-12 재확인 Maxim Group Buy
2015-01-09 재확인 MLV & Co Buy
2015-01-09 재확인 Maxim Group Buy
2014-12-19 재확인 Maxim Group Buy
2014-05-08 재확인 Maxim Group Buy
2014-03-14 재확인 MLV & Co Buy
2013-10-08 재확인 Maxim Group Buy
2012-01-05 개시 William Blair Outperform
2011-12-01 개시 Global Hunter Securities Buy
모두보기

아제너스 주식(AGEN)의 최신 뉴스

pulisher
03:57 AM

Is Agenus Inc. a good long term investmentUnprecedented market success - Autocar Professional

03:57 AM
pulisher
12:57 PM

Agenus Inc. Stock Analysis and ForecastMarket-beating performance - jammulinksnews.com

12:57 PM
pulisher
Jul 19, 2025

What analysts say about Agenus Inc. stockConsistently profitable trades - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Colon cancer impacts far more than just the body – Agenus - Oncodaily

Jul 19, 2025
pulisher
Jul 15, 2025

Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Zydus Lifesciences receives final approval from USFDA for Celecoxib Capsules - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

AGEN Stock Outpaces Medical Sector Peers This Year - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Agenus (AGEN) Surges 19.3%: Is This an Indication of Further Gains? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Public Companies Hold Majority of MiNK Therapeutics Stock After 815% Gain - AInvest

Jul 14, 2025
pulisher
Jul 12, 2025

Agenus Responds to New Regulatory Environment at FDA - Oncodaily

Jul 12, 2025
pulisher
Jul 11, 2025

Agenus Inc. shares surge 19.54% intraday after positive clinical data and strategic partnership. - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Zacks.com featured highlights Yext, Agenus and NCR Voyix - The Globe and Mail

Jul 10, 2025
pulisher
Jul 08, 2025

Agenus stock maintains Buy rating at H.C. Wainwright after positive bot/bal data - Investing.com Canada

Jul 08, 2025
pulisher
Jul 08, 2025

Investors Turn to Cancer Breakthroughs as Federal Funding Faces Deep Cuts - Baystreet.ca

Jul 08, 2025
pulisher
Jul 08, 2025

Agenus stock maintains Buy rating at H.C. Wainwright after positive bot/bal data By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 07, 2025

Agenus Inc. shares fall 1.35% in after-hours trading after FDA questions efficacy data for BOT/BAL combination. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Botensilimab and Balstilimab Achieves 21-Month Survival in mCRC and FDA Endorsement for Global Phase 3 Trial - Oncodaily

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus' BOT/BAL in MSS CRC: A Breakthrough with Accelerated Approval on the Horizon? - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus reports 42% two-year survival in colorectal cancer trial - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Agenus' BOT/BAL Combo Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward FDA Registration with Phase 3 Trial Design Alignment. - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

42% Survival Rate: Agenus Cancer Drug Shows Breakthrough in Resistant Colorectal Cancer | AGEN Stock News - Stock Titan

Jul 07, 2025
pulisher
Jul 07, 2025

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Jul 07, 2025
pulisher
Jul 03, 2025

Agenus Inc. shares surge 8.17% intraday after HC Wainwright & Co. analyst upgrades rating to strong buy. - AInvest

Jul 03, 2025
pulisher
Jul 03, 2025

Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN

Jul 03, 2025
pulisher
Jun 30, 2025

Agenus Requests to Dismiss Class Action Filed by Investors - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell 2000 Growth Index - MarketScreener

Jun 29, 2025
pulisher
Jun 29, 2025

Agenus Inc.(NasdaqCM: AGEN) dropped from Russell 2500 Index - MarketScreener

Jun 29, 2025
pulisher
Jun 20, 2025

Agenus Holds Annual Stockholders Meeting on June 17 - TipRanks

Jun 20, 2025
pulisher
Jun 18, 2025

# Agenus and Noetik partner to develop AI-powered cancer treatment biomarkers - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus (AGEN) and Noetik Collaborate to Enhance Cancer Treatment - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus, Noetik Enter Research Collaboration - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology | AGEN Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

AI Breakthrough: Agenus and Noetik Join Forces to Revolutionize Cancer Patient Selection Using Virtual Cell Models - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

10 Most Undervalued Stocks to Buy for Under $5 - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Is Zydus’s Agenus Deal Opportunistic Or Strategic? - insights.citeline.com

Jun 12, 2025
pulisher
Jun 11, 2025

Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 10, 2025

H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus Announces Virtual Annual Shareholders Meeting - New Castle News

Jun 10, 2025
pulisher
Jun 10, 2025

How to Join Agenus 2025 Virtual Shareholders Meeting: Complete Registration Guide - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus' 2025 Annual Meeting Highlights Pipeline Breakthroughs and Governance Gains, Bolstering Oncology Innovation Play - AInvest

Jun 10, 2025
pulisher
Jun 09, 2025

Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Research Analysts Issue Forecasts for Agenus FY2027 Earnings - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

HC Wainwright Forecasts Agenus’ Q3 Earnings (NASDAQ:AGEN) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million - Medical Dialogues

Jun 06, 2025

아제너스 (AGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):